Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GERD Segmentation: Document How Swiss GPs Allocate Their GERD Patients to the Three GERD Patient Segments

NCT00688675 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00688675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00688675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GERD Segmentation: Document How Swiss GPs Allocate Their GERD Patients to the Three GERD Patient Segments
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 29, 2008
Completion date
August 31, 2008
Enrollment
2,912 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gerd